Drug Search by Year (Detail)

25689342

US

Mental status changes, Suicide attempt, Sinus tachycardia, Pupillary reflex impaired, Mydriasis, Aspartate aminotransferase increased, Alanine aminotransferase increased, Overdose,

VALPROIC ACID, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE,

25689381

US

Sinus bradycardia, Heart rate decreased, Overdose, Drug abuse,

AMPHETAMINE, FENTANYL, LEVOCETIRIZINE DIHYDROCHLORIDE,

25689666

US

Overdose, Product use in unapproved indication, Therapeutic response unexpected,

CETIRIZINE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, DESVENLAFAXINE SUCCINATE, PACLITAXEL, DIPHENHYDRAMINE HYDROCHLORIDE,

25689668

US

Renal failure, Pseudohypoglycaemia, Contraindicated product administered, Hepatic enzyme abnormal, Overdose, Product use in unapproved indication, Product prescribing issue,

ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, GLIMEPIRIDE,

25690130

IR

Toxicity to various agents, Overdose,

MORPHINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMPHETAMINE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE,

25690961

EU

Overdose, Erythema, Fatigue, Rash, Stomatitis,

METHOTREXATE, METHOTREXATE SODIUM,

25690991

US

Blindness, Retinal toxicity, Visual field defect, Photophobia, Overdose,

SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,,

25691011

US

Overdose,

GUAIFENESIN,

25691267

US

Drug ineffective, Head discomfort, Overdose,

RIMEGEPANT SULFATE,

25691745

IN

Mucocutaneous ulceration, Asthenia, Overdose, Intentional product misuse, Toxicity to various agents, Diarrhoea, Pancytopenia, Febrile neutropenia,

METHOTREXATE SODIUM,

25691747

CA

Depression, Overdose,

HYDROXYZINE, UPADACITINIB,

25691752

IN

Dysphagia, Product prescribing error, Overdose, Pyrexia, Toxicity to various agents, Pancytopenia, Oral disorder,

METHOTREXATE SODIUM, FOLIC ACID,

25691854

JP

Renal impairment, Overdose,

LURASIDONE HYDROCHLORIDE,

25692704

CA

Dementia, Neurodegenerative disorder, Acute kidney injury, Delirium, Overdose, Rhabdomyolysis, Drug ineffective, Substance dependence,

BUPRENORPHINE, BUPRENORPHINE, MIRTAZAPINE, MIRTAZAPINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, NALOXONE, NALOXONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DONEPEZIL HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, DONEPEZIL HYDROCHLORIDE,

25690780

Product complaint, Dependence, Overdose, Respiratory depression, Product formulation issue,

25686594

US

Diastolic dysfunction, Rhinorrhoea, Overdose, Unresponsive to stimuli, Adulterated product, Hypertension, Miosis, Dizziness, Somnolence, Sedation, Mental status changes, Sinus bradycardia, Drug use disorder, Withdrawal syndrome,

DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, QUININE, FENTANYL,

25686611

US

Diastolic dysfunction, Overdose, Unresponsive to stimuli, Adulterated product, Sinus bradycardia, Miosis, Hypertension, Hypoxia, Mental status changes, Coma, Sedation, Drug use disorder,

DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MORPHINE, QUININE, FENTANYL,

25686616

US

Unresponsive to stimuli, Overdose, Adulterated product, Subdural haematoma, Haemorrhage, Sinus bradycardia, Hypertension, Sedation, Mental status changes, Lethargy, Muscle spasms, Drug use disorder,

DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FENTANYL,

25686843

US

Rhabdomyolysis, Seizure, Hypokalaemia, Overdose, Tachycardia, Factitious disorder, Developmental delay,

CAFFEINE CITRATE,

25687134

US

Toxicity to various agents, Overdose, Delirium, Affective disorder, Hypophagia, Tremor, Tachycardia, Hypotension, Electrocardiogram QT prolonged, Hypoglycaemia,

LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE,

25687405

SG

Encephalopathy, Overdose,

QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ESTAZOLAM, SERTRALINE,

25683928

CA

Condition aggravated, Fistula, Drug level above therapeutic, Hypertension, Intentional product use issue, Off label use, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID,

25683949

CA

Aphthous ulcer, Condition aggravated, Defaecation urgency, Mouth ulceration, Uveitis, Arthralgia, Fatigue, Infusion site pain, Intentional product use issue, Off label use, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB,

25683957

CA

Defaecation urgency, Condition aggravated, Eye disorder, Fistula, Abscess, Incorrect dose administered, Underdose, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, METRONIDAZOLE, METRONIDAZOLE TOPICAL,

25683967

CA

Abortion spontaneous, Overdose,

INFLIXIMAB, INFLIXIMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, LORAZEPAM, MESALAMINE, MESALAMINE, ALBUTEROL SULFATE, ALBUTEROL SULFATE,

25684101

CA

C-reactive protein increased, Influenza like illness, Red blood cell sedimentation rate increased, Productive cough, Pancreatic mass, Condition aggravated, Arthralgia, Bronchitis, Fatigue, Headache, Laryngitis, Nasopharyngitis, Pain, Pyrexia, Sinusitis, Knee arthroplasty, Off label use, Therapeutic response shortened, Incorrect dose administered, Underdose, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE,

25684122

CA

Blood pressure systolic increased, Condition aggravated, Haemorrhage, Joint stiffness, Joint swelling, Pulmonary embolism, Heart rate decreased, Weight increased, COVID-19, Chest pain, Dyspnoea, Fatigue, Headache, Heart rate irregular, Hypertension, Inappropriate schedule of product administration, Intentional product use issue, Off label use, Therapeutic response shortened, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM,

25684184

CA

Postpartum haemorrhage, Oral herpes, Skin infection, Intentional product use issue, Maternal exposure during pregnancy, Off label use, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB,

25684306

GB

Aggression, Anaemia, Decreased appetite, Confusional state, Depression, Diarrhoea, Oral discomfort, Dizziness, Syncope, Illness anxiety disorder, Insomnia, Muscle atrophy, Nausea, Overdose, Panic attack, Tremor, Suicidal ideation, Hyperhidrosis, Vomiting, Weight decreased, Generalised anxiety disorder,

SIMVASTATIN, SERTRALINE, ATENOLOL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PREGABALIN, PROMETHAZINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG,

25684316

CA

Abnormal faeces, Blood pressure fluctuation, Blood pressure increased, Body temperature fluctuation, Erythema, Frequent bowel movements, Gout, Heart rate decreased, Mucous stools, Pus in stool, COVID-19, Heart rate irregular, Hepatic infection, Oedema peripheral, Inappropriate schedule of product administration, Intentional product use issue, Off label use, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, IRON, METHOTREXATE, METHOTREXATE SODIUM,

25684345

CA

Condition aggravated, Ear discomfort, Ear pain, Eustachian tube dysfunction, Feeding disorder, Intestinal ulcer, Otorrhoea, Necrosis, Nephrolithiasis, Oropharyngeal pain, Tendon transfer, Meningitis viral, Abdominal pain, Haematochezia, Headache, Off label use, Intentional product use issue, Therapeutic response shortened, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN,

25684375

CA

Condition aggravated, Chills, Dizziness, Fatigue, Headache, Hyperhidrosis, Urinary tract infection, Inappropriate schedule of product administration, Underdose, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MESALAMINE, BUDESONIDE,

25684387

CA

Vaginal discharge, Anal fissure, Condition aggravated, Female genital tract fistula, Defaecation urgency, C-reactive protein increased, Haematocrit decreased, Drug level below therapeutic, Haemoglobin decreased, Mean cell haemoglobin decreased, Intestinal anastomosis, Poor venous access, Fistula, Cough, Erythema, Heart rate decreased, Arthralgia, Hypotension, Urticaria, Off label use, Overdose, Underdose, Intentional product use issue,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SACUBITRIL AND VALSARTAN, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MONTELUKAST, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), SOTALOL HYDROCHLORIDE,

25684408

EU

Chest pain, Nausea, Wrong dose, Overdose,

OLAPARIB,

25684474

CA

Arthralgia, Arthritis, C-reactive protein abnormal, COVID-19, Cataract, Condition aggravated, Drug level decreased, Drug specific antibody present, Dyspnoea, Ear pain, Emotional disorder, Gastric ulcer, Haemoglobin decreased, Haemorrhage, Hypertension, Infusion site discharge, Joint swelling, Ligament sprain, Lung disorder, Oedema peripheral, Pain, Peripheral swelling, Pneumonia, Pulmonary embolism, Renal disorder, Stress, Thrombosis, Visual impairment, Weight increased, Intentional product use issue, Off label use, Therapeutic response shortened, Underdose, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DESOXIMETASONE,

25684488

CA

Asthenia, Condition aggravated, Dry mouth, Drug level decreased, Peripheral coldness, Pharyngeal paraesthesia, Throat tightness, Chills, Back pain, Constipation, Dizziness, Nausea, Inappropriate schedule of product administration, Off label use, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE,

25684591

CA

Blood pressure increased, Condition aggravated, Discomfort, Muscle spasms, Neoplasm progression, Ocular hyperaemia, Weight fluctuation, Erythema nodosum, Skin cancer, Colorectal cancer, Arthralgia, Bronchitis, Otitis externa, Pneumonia, Drug level below therapeutic, Drug ineffective, Intentional product use issue, Off label use, Therapeutic response shortened, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FLUOROURACIL, MESALAMINE, PREDNISONE,

25684807

US

Overdose, Erosive oesophagitis, Hypersexuality, Pain, Malaise, Gastrooesophageal reflux disease, Oropharyngeal cobble stone mucosa, Nausea, Vomiting, Diarrhoea, Abdominal pain upper, Headache, Cough,

SETMELANOTIDE, SETMELANOTIDE, SETMELANOTIDE, SETMELANOTIDE, SETMELANOTIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FERROUS SULFATE, METOPROLOL TARTRATE, METOPROLOL, NAPROXEN, NAPROXEN SODIUM, ESOMEPRAZOLE MAGNESIUM, DESVENLAFAXINE SUCCINATE, ROSUVASTATIN, VALACYCLOVIR HYDROCHLORIDE, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, CETIRIZINE HYDROCHLORIDE, DUPILUMAB, FAMOTIDINE, HYDROXYZINE,

25685155

US

Seizure, Wrong technique in product usage process, Off label use, Overdose, Inappropriate schedule of product administration,

BRIVARACETAM, BRIVARACETAM, BRIVARACETAM, LACOSAMIDE, LACOSAMIDE, PERAMPANEL, PERAMPANEL, MIDAZOLAM,

25685320

CH

Shock, Acute kidney injury, Toxicity to various agents, Lactic acidosis, Overdose,

METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS,

25685399

CA

Blood pressure diastolic increased, Blood pressure increased, Condition aggravated, Rash pruritic, Weight decreased, Infusion site extravasation, Haemorrhage, Hypertension, Off label use, Drug level above therapeutic, Intentional product use issue, Intentional product use issue, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE,

25685598

US

Brain neoplasm, Cardiac failure congestive, Cardiac failure, Cerebrovascular accident, Chronic obstructive pulmonary disease, Thrombosis, Overdose,

FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE,

25685904

EU

Depressed level of consciousness, Feeling abnormal, Overdose,

SEMAGLUTIDE,

25686135

US

Road traffic accident, Disorientation, Feeling abnormal, Amnesia, Mania, Somnolence, Overdose,

SERTRALINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE,

25686474

US

Product dose omission issue, Inappropriate schedule of product administration, Overdose,

IXEKIZUMAB,

25678902

CA

Anal incontinence, Condition aggravated, Blood pressure increased, Bronchitis bacterial, Nausea, Pneumonia, Pneumonitis, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DEXLANSOPRAZOLE, MESALAMINE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, OXYBUTYNIN, PREDNISONE, PREDNISONE,

25678918

CA

Anxiety, Aphthous ulcer, Arthritis, Arthropod bite, Condition aggravated, Erythema, Fear, Feeling of despair, Inflammation, Joint swelling, Lip ulceration, Malaise, Mouth ulceration, Pain in extremity, Peripheral swelling, Rhinalgia, Epistaxis, Fatigue, Off label use, Inappropriate schedule of product administration, Intentional product use issue, Therapeutic response shortened, Underdose, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MESALAMINE, MESALAMINE, PREDNISONE,

25678933

CA

Blood pressure increased, Condition aggravated, Uveitis, Incorrect dose administered, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB,

25679090

CH

Disorientation, Pneumonia, Asthenia, Malaise, Mobility decreased, Device use issue, Product administration error, Diarrhoea, Asthenia, Pneumonia aspiration, Dyskinesia, Pyrexia, Overdose, Delirium,

25679250

CA

Aphthous ulcer, Blood pressure increased, Condition aggravated, Fistula, Pain, Purulent discharge, Abscess, Drug level decreased, Drug level below therapeutic, Therapeutic response shortened, Inappropriate schedule of product administration, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PREDNISONE,

25679325

CA

Condition aggravated, Irritable bowel syndrome, Constipation, Sinusitis bacterial, Intentional product use issue, Off label use, Therapeutic response shortened, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB,

25679492

CA

Condition aggravated, Diarrhoea, Off label use, Overdose, Underdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB,

25679536

CA

Haemoptysis, Musculoskeletal chest pain, Testicular mass, Testicular swelling, Abdominal pain, Nasopharyngitis, Fatigue, Pyrexia, Therapeutic response shortened, Off label use, Overdose, Underdose, Intentional product use issue,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DEXLANSOPRAZOLE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN,

25679598

IN

Depressed level of consciousness, Coma, Overdose, Toxicity to various agents, Altered state of consciousness, Loss of consciousness, Suicidal ideation, New onset refractory status epilepticus, Status epilepticus, Drug level increased,

CARBAMAZEPINE, CARBAMAZEPINE,

25679665

CA

Weight increased, Condition aggravated, Vomiting, Therapeutic product effect incomplete, Underdose, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE,

25679771

VN

Acute respiratory distress syndrome, Bradycardia, Cardiac dysfunction, Non-cardiogenic pulmonary oedema, Hypotension, Overdose,

AMLODIPINE,

25679791

GB

Cardiac arrest, Brain injury, Overdose,

RISPERIDONE, RISPERIDONE, OLANZAPINE, APIXABAN, SENNOSIDES, SENNA LEAF, SENNA, BISOPROLOL FUMARATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RAMIPRIL, LORAZEPAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVETIRACETAM,

25679812

CA

Cerebral venous sinus thrombosis, Hemiparesis, Anaemia, Overdose, Mental status changes, Drug withdrawal syndrome, Altered state of consciousness, Substance use,

METHADONE HYDROCHLORIDE, FENTANYL, AMPHETAMINE, BUPRENORPHINE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL,

25679820

US

Suicidal ideation, Antipsychotic drug level increased, Tremor, Drug effective for unapproved indication, Off label use, Overdose,

SOLRIAMFETOL, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, MODAFINIL, LISDEXAMFETAMINE DIMESYLATE, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, ACARBOSE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, DIAZEPAM, NALTREXONE, NALTREXONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LURASIDONE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE,

25679935

EU

Coma, Bezoar, Toxicity to various agents, Overdose,

QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE,

25680037

CA

Rash, Ill-defined disorder, Duodenal ulcer perforation, Synovitis, Fall, Taste disorder, Breast cancer stage III, Impaired healing, Stomatitis, Nausea, Product use in unapproved indication, Drug intolerance, Underdose, Rheumatoid arthritis, Hepatitis, Abdominal discomfort, Liver injury, Dyspnoea, Gait inability, Wound infection, Dyspepsia, Muscle spasms, Drug hypersensitivity, Migraine, Obesity, Injection site reaction, Folliculitis, Back injury, Hepatic enzyme increased, Hypercholesterolaemia, Memory impairment, Lung disorder, Weight increased, Onychomycosis, Onychomadesis, Contraindicated product administered, Off label use, Liver function test increased, Pneumonia, Musculoskeletal pain, Rheumatic fever, Blister, Hand deformity, Therapeutic product effect decreased, Overdose, Maternal exposure during pregnancy, Asthenia, Product label confusion, Intentional product use issue, Peripheral swelling, Injury, Muscular weakness, Insomnia, Osteoarthritis, Nasopharyngitis, Coeliac disease, Pain in extremity, Blepharospasm, Psoriatic arthropathy, Treatment failure, Helicobacter infection, Neck pain, Wound, Anti-cyclic citrullinated peptide antibody positive, Depression, Mobility decreased, Blood cholesterol increased, Hypoaesthesia, Joint swelling, Drug-induced liver injury, Arthralgia, Facet joint syndrome, Grip strength decreased, Irritable bowel syndrome, Drug ineffective, Decreased appetite, Headache, Abdominal pain upper, Inflammation, Musculoskeletal stiffness, Joint range of motion decreased, Adverse reaction, Pain, Systemic lupus erythematosus, C-reactive protein abnormal, Peripheral venous disease, Dizziness, Finger deformity, C-reactive protein increased, Type 2 diabetes mellitus, Hypersensitivity, Malaise, Exposure during pregnancy, General physical health deterioration, Fibromyalgia, Gastrooesophageal reflux disease, Sleep disorder, Confusional state, Night sweats, Alopecia, Diarrhoea, Urticaria, Condition aggravated, Gastrointestinal disorder, Vomiting, Lower respiratory tract infection, Dry mouth, Swelling, Pemphigus, Lip dry, Arthropathy, Epilepsy, Pericarditis, Abdominal distension, Product quality issue, Hypertension, Bursitis, Muscle injury, Paraesthesia, Glossodynia, Infusion related reaction, Nail disorder, Live birth, Incorrect product administration duration, Fatigue, Wheezing,

CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ATOMOXETINE, AZATHIOPRINE, ADALIMUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, MEPOLIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BUPRENORPHINE, ERENUMAB-AOOE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN AND CODEINE, CANDESARTAN, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, BOTULINUM TOXIN TYPE A, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ETANERCEPT, ETANERCEPT, ETANERCEPT,

25680105

CA

Blood iron decreased, Condition aggravated, Wound, Weight decreased, Off label use, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB,

25680123

EU

Bezoar, Toxicity to various agents, Coma, Overdose,

LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, QUETIAPINE FUMARATE, QUETIAPINE,

25680254

CA

Apathy, Arthralgia, Arthritis, Blood alkaline phosphatase increased, Bone swelling, Breast mass, Condition aggravated, Defaecation urgency, Disturbance in attention, Dyspnoea exertional, Energy increased, Eructation, Feeling of body temperature change, Flatulence, Food poisoning, Frequent bowel movements, Gait disturbance, Hyperaesthesia, Hyperhidrosis, Increased upper airway secretion, Inflammatory bowel disease, Nerve compression, Pain in extremity, Peripheral swelling, Peripheral venous disease, Pollakiuria, Skin disorder, Skin mass, Stress, Vein rupture, Weight increased, Abdominal distension, Asthenia, Back pain, Bronchitis, Chest discomfort, Dizziness, Dyspnoea, Fatigue, Gastrointestinal disorder, Gastrointestinal infection, Malaise, Nausea, Nervousness, Pain, Sinusitis, Off label use, Therapeutic response shortened, Underdose, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL,

25680282

CA

Dry mouth, Faeces discoloured, Oral pain, Diarrhoea, Off label use, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE,

25680289

CA

Abdominal distension, Aphthous ulcer, Erythema nodosum, Flatulence, Sinus congestion, Uveitis, Arthralgia, Constipation, Nausea, Therapeutic response shortened, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB,

25680371

IR

Overdose, Toxicity to various agents,

MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMPHETAMINE, MORPHINE,

25680483

CA

Anal fissure, Aphthous ulcer, Condition aggravated, Drug level abnormal, Erythema nodosum, Pyoderma gangrenosum, Arthralgia, Bronchitis, Intentional product use issue, Off label use, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB,

25680548

EU

Confusional state, Hallucination, Aggression, Overdose,

FLUCONAZOLE,

25680779

US

Dopamine dysregulation syndrome, Intentional product misuse, Overdose,

CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, FENTANYL,

25680781

CA

Arthropod bite, Condition aggravated, Oropharyngeal pain, Cough, Arthralgia, Fatigue, Headache, COVID-19, Drug ineffective, Off label use, Overdose, Underdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DULOXETINE HYDROCHLORIDE,

25681090

EU

Clostridium difficile colitis, Overdose,

FENTANYL, FENTANYL, FENTANYL, FENTANYL, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, DAPTOMYCIN, DAPTOMYCIN, DAPTOMYCIN, DAPTOMYCIN, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM,

25681173

US

Incorrect dose administered, Overdose, Product cleaning inadequate, Discontinued product administered,

BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE,

25681240

US

Multiple organ dysfunction syndrome, Overdose,

COCAINE HYDROCHLORIDE NASAL,

25681608

GB

Brain injury, Cardiac arrest, Brain injury, Overdose,

RISPERIDONE, RISPERIDONE, OLANZAPINE, OLANZAPINE, APIXABAN, SENNOSIDES, SENNA LEAF, SENNA, BISOPROLOL FUMARATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RAMIPRIL, LORAZEPAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVETIRACETAM,

25682150

CA

Arteriosclerosis coronary artery, Cardio-respiratory arrest, Death, Toxicity to various agents, Drug dependence, Drug abuse, Overdose, Poisoning, Off label use, Product use in unapproved indication,

DIAZEPAM, CLONAZEPAM, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, OXAZEPAM, PREGABALIN, TEMAZEPAM, DRONABINOL, OXYCODONE HYDROCHLORIDE, OXYCODONE, METHYLPHENIDATE HYDROCHLORIDE, FENTANYL, PREGABALIN, OXYCODONE, NALOXONE,

25682178

EU

Methaemoglobinaemia, Overdose,

IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SODIUM NITRITE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE,

25682232

US

Victim of homicide, Counterfeit product administered, Overdose,

OXYCODONE HYDROCHLORIDE, OXYCODONE, FENTANYL,

25682325

Overdose, Wrong technique in device usage process, Product preparation error, Product prescribing issue, Product communication issue, Renal failure, Haemodialysis, Acute respiratory failure, Drug monitoring procedure not performed, Peritoneal dialysis,

DARBEPOETIN ALFA, METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,

25682374

Dependence, Overdose,

25682543

CA

Adverse reaction, Ill-defined disorder, Rash, Duodenal ulcer perforation, Insomnia, Epilepsy, Anti-cyclic citrullinated peptide antibody positive, Gastrointestinal disorder, Obesity, Hypersensitivity, Memory impairment, Abdominal distension, Blister, Fatigue, Dizziness, Glossodynia, Fibromyalgia, Asthenia, Hypoaesthesia, Impaired healing, Dyspnoea, Lip dry, Lung disorder, Dry mouth, Muscle injury, Pemphigus, Migraine, Hepatitis, Onychomadesis, Blood cholesterol increased, Alopecia, Nail disorder, Peripheral swelling, Abdominal pain upper, Malaise, Diarrhoea, Inflammation, Hepatic enzyme increased, Abdominal discomfort, Hand deformity, Weight increased, Vomiting, Urticaria, Wheezing, Type 2 diabetes mellitus, Taste disorder, Hypertension, Fall, Hypercholesterolaemia, Dyspepsia, Wound, Decreased appetite, Gastrooesophageal reflux disease, Swelling, Systemic lupus erythematosus, Neck pain, Rheumatic fever, Drug-induced liver injury, Headache, Stomatitis, Injection site reaction, Pericarditis, Peripheral venous disease, Muscle spasms, Infusion related reaction, Depression, Nausea, Night sweats, Coeliac disease, Liver injury, Paraesthesia, Blepharospasm, Confusional state, Irritable bowel syndrome, Drug hypersensitivity, Injury, Back injury, Sleep disorder, Liver function test increased, Synovitis, Pain, Musculoskeletal stiffness, Joint range of motion decreased, Arthropathy, Grip strength decreased, Gait inability, C-reactive protein abnormal, C-reactive protein increased, General physical health deterioration, Muscular weakness, Osteoarthritis, Pain in extremity, Psoriatic arthropathy, Mobility decreased, Rheumatoid arthritis, Facet joint syndrome, Musculoskeletal pain, Bursitis, Finger deformity, Joint swelling, Arthralgia, Condition aggravated, Wound infection, Pneumonia, Breast cancer stage III, Nasopharyngitis, Folliculitis, Helicobacter infection, Onychomycosis, Lower respiratory tract infection, Maternal exposure during pregnancy, Exposure during pregnancy, Live birth, Treatment failure, Therapeutic product effect decreased, Drug ineffective, Drug intolerance, Underdose, Overdose, Incorrect product administration duration, Product use in unapproved indication, Intentional product use issue, Contraindicated product administered, Product label confusion, Product quality issue, Off label use,

ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, ANTACID, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, MEPOLIZUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ACETAMINOPHEN AND CODEINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, CANDESARTAN, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, ERENUMAB-AOOE,

25682806

US

Fall, Ankle fracture, Overdose,

LECANEMAB,

25682824

GB

Overdose, Off label use,

CLOZAPINE, CLOZAPINE,

25682867

US

Overdose,

TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE,

25683084

US

Seizure, Anxiety, Insomnia, Stress, Amnestic disorder, Product dose omission issue, Overdose, Product use issue,

LACOSAMIDE, LACOSAMIDE, LEVETIRACETAM, LEVETIRACETAM, OXCARBAZEPINE, OXCARBAZEPINE, CLONAZEPAM, FISH OIL, ERGOCALCIFEROL,

25683351

US

Cardiac failure, Overdose, Drug dependence, Adverse event,

OXYCODONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE,

25673240

Pneumonia, Hypoxia, Endotracheal intubation, Inappropriate schedule of product administration, Overdose,

METHOTREXATE, METHOTREXATE SODIUM, ALLOPURINOL, AMLODIPINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CELECOXIB, LANSOPRAZOLE, VALSARTAN, VALSARTAN ORAL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FOLIC ACID, COLCHICINE,

25673439

US

Off label use, Overdose,

CETIRIZINE HYDROCHLORIDE,

25673650

CH

Shock, Acute kidney injury, Intentional product misuse, Toxicity to various agents, Overdose,

AMLODIPINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, LEVOTHYROXINE, MIRTAZAPINE, PREGABALIN,

25673994

CA

Dyspnoea, Depressed level of consciousness, Mobility decreased, Creatinine renal clearance increased, Drug interaction, Drug abuse, Blood calcium decreased, Off label use, Hypotension, Balance disorder, Product use in unapproved indication, Orthostatic hypotension, Sedation complication, Sedation, Cognitive disorder, Constipation, Renal function test abnormal, Fall, Multiple drug therapy, Pain, Toxicity to various agents, Overdose, Creatinine renal clearance decreased,

AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, DIPYRIDAMOLE, DIPYRIDAMOLE, DIPYRIDAMOLE, DIPYRIDAMOLE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PERPHENAZINE, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, QUININE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CYCLOBENZAPRINE, CYCLOBENZAPRINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, MAGNESIUM HYDROXIDE, MAGNESIUM HYDROXIDE, MAGNESIUM HYDROXIDE, MAGNESIUM HYDROXIDE, OXCARBAZEPINE, ERGOCALCIFEROL, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, LACTULOSE, LACTULOSE, LACTULOSE, LACTULOSE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PHOSPHORIC ACID, ATROPINE SULFATE, ATROPINE, ATROPINE SULFATE, ATROPINE, ATROPINE SULFATE, ATROPINE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, FUROSEMIDE, ROSUVASTATIN CALCIUM, AMINOPHYLLINE, AMINOPHYLLINE, AMINOPHYLLINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CYCLOBENZAPRINE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, PHENYLEPHRINE HYDROCHLORIDE, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, GALANTAMINE HYDROBROMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, CAFFEINE CITRATE, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN,

25674020

JP

Toxicity to various agents, Completed suicide, Overdose, Cardiac arrest,

DEXTROMETHORPHAN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE,

25674604

EU

Overdose, Analgesic drug level increased,

ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER,

25674631

EU

Peripheral ischaemia, Incorrect dose administered, Overdose,

NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE,

25674700

US

Back pain, Vomiting, Drug interaction, Brain oedema, Drug abuse, Overdose, Pulmonary oedema, Toxicity to various agents,

MORPHINE, OXYCODONE, CAFFEINE,

25674896

GB

Overdose, Hospitalisation,

CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER,

25674897

CH

Drug dependence, Aggression, Drug abuse, Overdose, Feeling abnormal, Withdrawal syndrome,

ALPRAZOLAM,

25675117

US

Haemorrhagic transformation stroke, Toxicity to various agents, Bradycardia, Cardiogenic shock, Hypoperfusion, Cerebral haemorrhage, Overdose,

FLUOXETINE HYDROCHLORIDE, FLUOXETINE, METOPROLOL TARTRATE, METOPROLOL,

25675232

US

Adverse event, Product use issue, Intentional product misuse, Overdose,

25675473

US

Incorrect dose administered by device, Overdose, Product dose omission issue, Wrong technique in product usage process, Device delivery system issue,

ALBUTEROL SULFATE AND BUDESONIDE,

25675498

CA

Oxygen saturation decreased, Blood pressure increased, Drug level decreased, Uveitis, Arthralgia, Intentional product use issue, Off label use, Off label use, Product use issue, Overdose,

INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE,